Viewing Study NCT04337593


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-02-20 @ 5:57 PM
Study NCT ID: NCT04337593
Status: UNKNOWN
Last Update Posted: 2020-04-07
First Post: 2020-04-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Basiliximab and Pegaspargase in the Treatment of ENKTCL
Sponsor: Beijing Tongren Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extranodal NK/T-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None extranodal NK/T-cell lymphoma View
None basiliximab View
None pegaspargase View
None CD25 View